Streptase (Aventis Behringer GmbH)
Streptase (Aventis Behringer GmbH) Brand names, Streptase (Aventis Behringer GmbH) Analogs
Streptase (Aventis Behringer GmbH) Brand Names Mixture
- No information avaliable
Streptase (Aventis Behringer GmbH) Chemical_Formula
C2100H3278N566O669S4
Streptase (Aventis Behringer GmbH) RX_link
http://www.rxlist.com/cgi/generic2/streptokinase.htm
Streptase (Aventis Behringer GmbH) fda sheet
Streptase (Aventis Behringer GmbH) msds (material safety sheet)
Streptase (Aventis Behringer GmbH) Synthesis Reference
No information avaliable
Streptase (Aventis Behringer GmbH) Molecular Weight
47286.7
Streptase (Aventis Behringer GmbH) Melting Point
No information avaliable
Streptase (Aventis Behringer GmbH) H2O Solubility
No information avaliable
Streptase (Aventis Behringer GmbH) State
Liquid
Streptase (Aventis Behringer GmbH) LogP
-0.728
Streptase (Aventis Behringer GmbH) Dosage Forms
Powder for solution; Solution (IV infusion)
Streptase (Aventis Behringer GmbH) Indication
For the treatment of acute evolving transmural myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thrombosis or embolism and occlusion of arteriovenous cannulae
Streptase (Aventis Behringer GmbH) Pharmacology
Streptokinase cleaves the Arg/Val bond in plasminogen to form the proteolytic enzyme plasmin. Plasmin in turn degrades the fibrin matrix of the thrombus, thereby exerting its thrombolytic action. This helps eliminate blood clots or arterial blockages that cause myocardial infarction.
Streptase (Aventis Behringer GmbH) Absorption
No information avaliable
Streptase (Aventis Behringer GmbH) side effects and Toxicity
No information avaliable
Streptase (Aventis Behringer GmbH) Patient Information
No information avaliable
Streptase (Aventis Behringer GmbH) Organisms Affected
Humans and other mammals
